In 2015, the pharma and biotech industry was diagnosed with what was coined as merger fever. Industry analysts state that the first half of 2015 soared past 2014’s grand total of $162 billion, with the total value of pharma M&As in the first two quarte

Pharma & Biotech’s Merger Fever: The Highlights


Please note: That all fields marked with an asterisk (*) are required.